Fortress Financial Group LLC acquired a new stake in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 987 shares of the healthcare conglomerate’s stock, valued at approximately $499,000.
Other institutional investors and hedge funds have also bought and sold shares of the company. AlphaMark Advisors LLC purchased a new stake in UnitedHealth Group in the fourth quarter valued at $30,000. RPg Family Wealth Advisory LLC acquired a new stake in UnitedHealth Group during the third quarter worth about $37,000. DecisionPoint Financial LLC boosted its position in UnitedHealth Group by 155.0% in the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock worth $52,000 after purchasing an additional 62 shares in the last quarter. Highline Wealth Partners LLC purchased a new position in shares of UnitedHealth Group during the 3rd quarter valued at approximately $55,000. Finally, Legacy Investment Solutions LLC purchased a new stake in UnitedHealth Group during the third quarter worth $57,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently issued reports on the stock. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price on the stock in a research note on Friday, January 10th. Barclays cut their price target on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research report on Friday, January 17th. Stephens increased their target price on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research note on Thursday, December 5th. Piper Sandler reduced their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research note on Thursday, January 2nd. Finally, Cantor Fitzgerald reissued an “overweight” rating and set a $700.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. One analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Buy” and an average price target of $629.32.
UnitedHealth Group Stock Up 1.2 %
NYSE UNH opened at $469.11 on Friday. The stock has a market cap of $431.71 billion, a PE ratio of 30.26, a P/E/G ratio of 1.37 and a beta of 0.61. The business has a 50 day moving average price of $517.10 and a two-hundred day moving average price of $557.79. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73.
UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the prior year, the firm posted $5.83 EPS. The firm’s revenue was up 6.8% compared to the same quarter last year. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Investors of record on Monday, March 10th will be paid a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.79%. The ex-dividend date is Monday, March 10th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.
Insider Buying and Selling at UnitedHealth Group
In related news, Director Timothy Patrick Flynn bought 1,000 shares of the firm’s stock in a transaction on Friday, January 17th. The stock was bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.33% of the stock is owned by insiders.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading
- Five stocks we like better than UnitedHealth Group
- Top Biotech Stocks: Exploring Innovation Opportunities
- Salesforce’s Hidden Strengths Could Fuel a Powerful Rebound
- Health Care Stocks Explained: Why You Might Want to Invest
- 3 Stocks With Unusual Call Option Volume – What It Signals
- What is the Australian Securities Exchange (ASX)
- Top 4 Healthcare REITs Turning Care Into Big Investor Payouts
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.